Appetite suppression timelines vary from person to person, which is why proper dosing, monitoring, and metabolic support matter
This resource is designed for PTs, ATCs, and rehabilitation providers who refer patients to Thrive for enhanced healing during their post-operative rehab process
That's a terrific zero cost way to support us
10.1007/s12551-023-01054-9 129 NussinovR.YavuzB
Patients who experience persistent palpitations beyond 8 weeks at a stable dose should undergo formal cardiac evaluation, including ECG and Holter monitoring, to rule out atrial fibrillation or other arrhythmias that GLP-1 therapy may have unmasked rather than caused
Key considerations include: 1-2 intramuscular injections per week, typically for 4-8 weeks